Rifampin-monoresistant tuberculosis in New York City, 1993-1994

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
S S MunsiffT R Frieden

Abstract

All New York City patients whose cultures yielded Mycobacterium tuberculosis with isolated resistance to rifampin in 1993 and 1994 were included in this study. Of the 96 patients, 48 (50%) had primary resistance, 32 (33%) had acquired resistance, and 16 (17%) had unclassified resistance; 66% had histories of illicit drug use, and 79% were infected with human immunodeficiency virus (HIV). The median time to emergence of resistance was 40 weeks among the 32 patients with acquired resistance. Each of the HIV-infected patients with acquired resistance (cases, n = 29) was matched to two HIV-infected patients who had disease due to fully susceptible M. tuberculosis (controls, n = 58). In multivariate analysis, factors associated with the emergence of rifampin resistance were as follows: a sputum smear positive for acid-fast bacilli, advanced immunosuppression, and nonadherence to therapy.

Citations

Jul 3, 2003·The Lancet Infectious Diseases·Amy Sarah GinsburgWilliam R Bishai
Feb 4, 1999·The New England Journal of Medicine·D V Havlir, P F Barnes
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M J SotirH M Blumberg
Oct 12, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C R DriverS S Osahan
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Amy Sarah GinsburgTimothy R Sterling
Feb 7, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David C PerlmanUNKNOWN ACTG 309 Team
Jun 7, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jiehui LiJudith Sackoff
Aug 30, 2007·The Journal of Infectious Diseases·Charles D WellsKarin Weyer
Dec 12, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Travis C PorcoJennifer M Flood
May 6, 1999·Current Opinion in Pulmonary Medicine·C S HirschJ J Ellner
Oct 8, 2011·The Pediatric Infectious Disease Journal·Andrea T Cruz, Jeffrey R Starke
Jan 30, 2004·Annual Review of Medicine·Bouke C de JongPeter M Small
Jul 28, 2009·Annual Review of Medicine·Sheela Shenoi, Gerald Friedland
Feb 2, 1999·American Journal of Respiratory and Critical Care Medicine·L SandmanS Bonk
Jul 4, 2001·Clinical Pharmacokinetics·W J BurmanC Peloquin
Jan 13, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·F K MukindaH S Schaaf
Apr 22, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marc WeinerUNKNOWN Tuberculosis Trials Consortium
Jan 15, 2014·BMC Infectious Diseases·Vanina MeyssonnierJérôme Robert
Dec 4, 2003·Wiener klinische Wochenschrift·Muktar H Aliyu, Hamisu M Salihu
Apr 29, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L AaronO Lortholary
Mar 2, 2002·The Lancet Infectious Diseases·B M FarrR J Sherertz
Dec 9, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher VinnardShama Ahuja
Sep 7, 2017·Antimicrobial Agents and Chemotherapy·Sang-Won ParkEric L Nuermberger
Jun 25, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lisa SharlingSundari Mase
May 9, 2007·Cadernos de saúde pública·Luciana Martins RozmanMauro Abrahão Rozman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Related Papers

American Journal of Respiratory and Critical Care Medicine
R RidzonI M Onorato
American Journal of Respiratory and Critical Care Medicine
L SandmanS Bonk
American Journal of Respiratory and Critical Care Medicine
M LutfeyB N Kreiswirth
American Journal of Respiratory and Critical Care Medicine
C M NolanS V Goldberg
© 2021 Meta ULC. All rights reserved